S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils

S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils

Abstract S100A11 (calgizzarin), a member of S100 family, is associated with several autoimmune diseases, including rheumatoid arthritis (RA). Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of RA and in the externalization of some S100 family members. Therefore, we aimed to...

Full description

Bibliographic Details
Main Authors:	Adéla Navrátilová, Viktor Bečvář, Jiří Baloun, Dres Damgaard, Claus Henrik Nielsen, David Veigl, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Lucie Andrés Cerezo
Format:	Article
Language:	English
Published:	Nature Portfolio 2021-03-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-021-85561-3

Similar Items

Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis
by: Lucie Andrés Cerezo, et al.
Published: (2017-04-01)

IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis
by: Adela Navrátilová, et al.
Published: (2021-10-01)

New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis
by: Karel Pavelka, et al.
Published: (2023-04-01)

Chemokine and Cytokine Profiles in Patients with Hand Osteoarthritis
by: Jiří Baloun, et al.
Published: (2020-12-01)

Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin. <i>Biomedicines</i> 2021, <i>9</i>, 650
by: Hana Štorkánová, et al.
Published: (2023-10-01)

Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
by: Hana Štorkánová, et al.
Published: (2021-06-01)

Menopausal Transition: Prospective Study of Estrogen Status, Circulating MicroRNAs, and Biomarkers of Bone Metabolism
by: Jiri Baloun, et al.
Published: (2022-05-01)

Interleukin-37: associations of plasma levels and genetic variants in gout
by: Lucie Andres Cerezo, et al.
Published: (2023-10-01)

Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study
by: Barbora Heřmánková, et al.
Published: (2024-12-01)

Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study
by: Barbora Heřmánková, et al.
Published: (2023-05-01)

Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.
by: Ladislav Šenolt, et al.
Published: (2015-01-01)

High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
by: Klára Prajzlerová, et al.
Published: (2021-02-01)

S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity
by: Barbora Šumová, et al.
Published: (2020-01-01)

Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
by: Dres Damgaard, et al.
Published: (2018-01-01)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
by: Rehman, I, et al.
Published: (2004)

Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response
by: Tereza Kropáčková, et al.
Published: (2021-06-01)

Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort.
by: Ondřej Sglunda, et al.
Published: (2014-01-01)

Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry
by: Lucie Nekvindová, et al.
Published: (2021-01-01)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
by: Rehman, I, et al.
Published: (2003)

The Prevalence of MRI-Defined Sacroiliitis and Classification of Spondyloarthritis in Patients with Acute Anterior Uveitis: A Longitudinal Single-Centre Cohort Study
by: Kristyna Bubova, et al.
Published: (2022-01-01)

Identification of Novel Native Autoantigens in Rheumatoid Arthritis
by: Thomas B. G. Poulsen, et al.
Published: (2020-05-01)

Cardiovascular Risk in Myositis Patients Compared to the General Population: Preliminary Data From a Single-Center Cross-Sectional Study
by: Sabina Oreska, et al.
Published: (2022-05-01)

Vital NETosis vs. suicidal NETosis during normal pregnancy and preeclampsia
by: Florence Guillotin, et al.
Published: (2023-01-01)

Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.
by: Jana Hurnakova, et al.
Published: (2016-01-01)

Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
by: Jana Hurnakova, et al.
Published: (2017-01-01)

Regulating NETosis: Increasing pH Promotes NADPH Oxidase-Dependent NETosis
by: Meraj A. Khan, et al.
Published: (2018-02-01)

Platelet-neutrophil crosstalk and netosis
by: Konstantin Stark
Published: (2019-06-01)

Receptor-Mediated NETosis on Neutrophils
by: Tao Chen, et al.
Published: (2021-11-01)

Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNF-α therapy effectiveness
by: Patricia Ruiz-Limon, et al.
Published: (2020-04-01)

The effect of a 24-week training focused on activities of daily living, muscle strengthening, and stability in idiopathic inflammatory myopathies: a monocentric controlled study with follow-up
by: Maja Špiritović, et al.
Published: (2021-06-01)

Are TNF inhibitors still the agent of choice for RA?
by: Taylor, PC
Published: (2023)

Netosis in patients with systemic lupus erythematosus
by: V. V. Zhelezko, et al.
Published: (2020-12-01)

Death of tonsillar B cells by NETosis
by: Ameera Bukhari, et al.
Published: (2023-03-01)

The severity of netosis in patients with neonatal sepsis
by: Kh. S. Khaertynov, et al.
Published: (2020-11-01)

Heterotypic intercellular interactions as regulators of NETosis
by: Nayef M. Kazzaz, et al.
Published: (2016-11-01)

Editorial: NETosis 2: The Excitement Continues
by: Luis E. Muñoz, et al.
Published: (2017-10-01)

NETosis as source of autoantigens in rheumatoid arthritis
by: Elisa Corsiero, et al.
Published: (2016-11-01)

Diverse Roles of NETosis in the Pathogenesis of Lupus
by: Meiying Wang, et al.
Published: (2022-05-01)

Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4
by: María Teresa Martín Monreal, et al.
Published: (2021-10-01)

NETosis in Wound Healing: When Enough Is Enough
by: Maurizio Sabbatini, et al.
Published: (2021-02-01)